PRE
- Product code
- PRE
- Device name
- Rt-Qpcr Assay For Mrna Transcript Immune Biomarkers
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.3215
- Medical specialty
- Microbiology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 2
- Summaries archived here
- 1 (direct download)
- 510(k) clearances (all years, FDA)
- 4 (all years; only the last 3 years are listed here)
FDA classification definition
A quantitative gene expression assay using reverse transcription polymerase chain reaction to quantify the relative expression levels of host response genes isolated from whole blood.
510(k) clearances, last 3 years (2)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K241676 | 2025-01-10 | Inflammatix, Inc. | TriVerity | |
| K232095 | 2023-12-15 | Immunexpress, Inc. | SeptiCyte RAPID | — |
Official FDA classification page: PRE
Classification and pathway per current FDA publications. Data from openFDA (CC0).